Skip to main content

Volume 2 Supplement 2

Proceedings of the Experts Meeting on Lung Cancer and the Use of Erlotinib

Proceedings

Edited by Aldo Castagnari

Publication of this supplement was supported by Laboratorios Roche Syntex México

Experts Meeting on Lung Cancer and the Use of Erlotinib.

New York, USA10 November 2007

Annual Journal Metrics

  • 2022 Citation Impact
    0.914 - SNIP (Source Normalized Impact per Paper)
    0.506 - SJR (SCImago Journal Rank)

    2023 Usage 
    640,615 downloads
    196 Altmetric mentions